{"id":3465,"date":"2023-03-28T11:59:32","date_gmt":"2023-03-28T17:59:32","guid":{"rendered":"https:\/\/www.uv.mx\/dic\/?p=3465"},"modified":"2023-03-28T12:03:12","modified_gmt":"2023-03-28T18:03:12","slug":"bibliografia-3","status":"publish","type":"post","link":"https:\/\/www.uv.mx\/dic\/general\/bibliografia-3\/","title":{"rendered":"Bibliograf\u00eda-3"},"content":{"rendered":"

Sistema glicin\u00e9rgico<\/strong><\/p>\n

    \n
  1. Dresbach, T., Nawrotzki, R., Kremer, T. et al. Molecular architecture of glycinergic synapses. Histochem Cell Biol 130, 617\u2013633 (2008). https:\/\/doi.org\/10.1007\/s00418-008-0491-y<\/a><\/li>\n
  2. Kirsch, J. Transmisi\u00f3n glicin\u00e9rgica. Cell Tissue Res 326 , 535\u2013540 (2006). https:\/\/doi.org\/10.1007\/s00441-006-0261-x<\/a>.<\/li>\n
  3. Gamlin, C. R., Yu, W. Q., Wong, R., & Hoon, M. (2018). Assembly and maintenance of GABAergic and Glycinergic circuits in the mammalian nervous system. Neural development, 13(1), 12. https:\/\/doi.org\/10.1186\/s13064-018-0109-6<\/a>.<\/li>\n
  4. Peiser-Oliver, J. M., Evans, S., Adams, D. J., Christie, M. J., Vandenberg, R. J., & Mohammadi, S. A. (2022). Glycinergic Modulation of Pain in Behavioral Animal Models. Frontiers in pharmacology, 13, 860903. https:\/\/doi.org\/10.3389\/fphar.2022.860903<\/a>.<\/li>\n
  5. Zeilhofer, HU, Acu\u00f1a, MA, Gingras, J. et al. Receptores de glicina y transportadores de glicina: \u00bfdianas para nuevos analg\u00e9sicos?. C\u00e9lula. mol. Ciencias de la vida 75 , 447\u2013465 (2018). https:\/\/doi.org\/10.1007\/s00018-017-2622-x<\/a>.<\/li>\n
  6. Legendre, P. La sinapsis inhibitoria glicin\u00e9rgica. CMLS, Celular. mol. Ciencias de la vida 58 , 760\u2013793 (2001). https:\/\/doi.org\/10.1007\/PL00000899<\/a><\/li>\n
  7. Lynch, J. W., Zhang, Y., Talwar, S., & Estrada-Mondragon, A. (2017). Glycine Receptor Drug Discovery. Advances in pharmacology (San Diego, Calif.), 79, 225\u2013253. https:\/\/doi.org\/10.1016\/bs.apha.2017.01.003<\/a>.<\/li>\n<\/ol>\n

    Sistema noradren\u00e9rgico<\/strong><\/p>\n

      \n
    1. Tellez Vargas, Jorge. (2000). La noradrenalina su rol en la depresi\u00f3n. Revista Colombiana de Psiquiatr\u00eda, 29(1), 50-73. Retrieved January 12, 2023, from http:\/\/www.scielo.org.co\/scielo.php?script=sci_arttext&pid=S0034-74502000000100006&lng=en&tlng=es<\/a><\/li>\n
    2. Hussain LS, Reddy V, Maani CV. Fisiolog\u00eda, Sinapsis Noradren\u00e9rgica. [Actualizado el 8 de mayo de 2022]. En: StatPearls [Internet]. Treasure Island (FL): Publicaci\u00f3n de StatPearls; 2022 ene-. Disponible en: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK540977\/<\/a><\/li>\n
    3. Dell’Osso, B., Palazzo, M. C., Oldani, L., & Altamura, A. C. (2011). The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects. CNS neuroscience & therapeutics, 17(6), 723\u2013732. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00217.x<\/a>.<\/li>\n
    4. Andrew K. Evans, Pooneh M. Ardestani, Bitna Yi, Heui Hye Park, Rachel K. Lam, Mehrdad Shamloo,Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer’s Disease,Neurobiology of Disease,Volume 146,2020,105089,ISSN 0969-9961, https:\/\/doi.org\/10.1016\/j.nbd.2020.105089<\/a><\/li>\n
    5. Yamamoto, K., Shinba, T., & Yoshii, M. (2014). Psychiatric symptoms of noradrenergic dysfunction: a pathophysiological view. Psychiatry and clinical neurosciences, 68(1), 1\u201320. https:\/\/doi.org\/10.1111\/pcn.12126<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

      Sistema glicin\u00e9rgico Dresbach, T., Nawrotzki, R., Kremer, T. et al. Molecular architecture of glycinergic synapses. Histochem Cell Biol 130, 617\u2013633 (2008). https:\/\/doi.org\/10.1007\/s00418-008-0491-y Kirsch, J. Transmisi\u00f3n glicin\u00e9rgica. Cell Tissue Res 326 , 535\u2013540 (2006). https:\/\/doi.org\/10.1007\/s00441-006-0261-x. Gamlin, C. R., Yu, W. Q., Wong, R., & Hoon, M. (2018). Assembly and maintenance of GABAergic and Glycinergic circuits in […]<\/p>\n","protected":false},"author":1696,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ventana_nueva":"","tipo_url":"","url":"","extracto":"","imagen_halign":"","imagen_valign":"","bg_size":"","text_hide":"","media_url":"","tipo_media":"","video_url":"","video_pos":"","video_youtube":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-3465","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/posts\/3465","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/users\/1696"}],"replies":[{"embeddable":true,"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/comments?post=3465"}],"version-history":[{"count":2,"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/posts\/3465\/revisions"}],"predecessor-version":[{"id":3468,"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/posts\/3465\/revisions\/3468"}],"wp:attachment":[{"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/media?parent=3465"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/categories?post=3465"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.uv.mx\/dic\/wp-json\/wp\/v2\/tags?post=3465"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}